The Board of Directors of NATCO Pharma Limited at their meeting held on February 14, 2024, have Declared third interim dividend of INR 1.25/- (Rupees one and paise twenty five only) (62.50%) each per equity share of INR 2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment of third interim dividend i.e., record date is fixed as the 26 February 2024. The payment of said interim dividend will start from 4 March 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
990 INR | +1.59% | -0.50% | +22.01% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.01% | 2.09B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024